If the data turns out similar to that from MSK, I can easily see a future phase III trial with this combination versus either IPI or PD-1 alone. This could very well become a new standard of care if everything continues to look good.
Frank, how close is the University of Indiana to you?
Caught my name out of the corner of my eye. About a day’s drive away. I’m 8 days away plus from my two seizures now and will get the oncologist’s action summary a week from Tuesday as I continue on Keppra and Dexamethasone this week in declining amounts. My thought would be that I would be ineligible for a while for anything PD-1 until the brain met issue is resolved. It would not surprise me if a reinduction of ipi is recommended ASAP given the U. of M. protocol as I know it at this moment. Maybe hand in hand with SRS or even craniotomy, since there only seems to be one. But that was last week